Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease

Emily P. McQuarrie, Ellen Marie Freel, Patrick B. Mark, Robert Fraser, John M. C. Connell, Alan G. Jardine

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    BackgroundBlockade of the mineralocorticoid receptor (MR) in patients with chronic kidney disease (CKD) improves surrogate cardiovascular outcomes, such as left ventricular mass. Animal models of renal disease support a pathological role of mineralocorticoids, in the context of a high sodium intake. We aimed to assess the regulation of mineralocorticoid biosynthesis in patients with CKD.MethodsSeventy patients with CKD stages 3/4 and 30 patients with essential hypertension (EH) were recruited. Patients underwent detailed clinical phenotyping, drug history and biochemical assessment. Patients completed a 24-h urine collection for measurement of urinary tetrahydroaldosterone (THALDO) and tetrahydrocorticosterone (THDOC) excretion rates (measured using gas chromatography-mass spectrometry) and urinary electrolytes. The factors which correlated significantly with THALDO and THDOC excretion were entered into linear regression models.ResultsPatients with EH and CKD were well matched with no significant differences in gender, age or weight. The mean estimated glomerular filtration rate (eGFR) in CKD patients was 38.6/min/1.73 m . The mean urinary excretion rates of THALDO, THDOC and 24-h urinary sodium (24-h USod) were not significantly different between CKD and EH patients. The level of renal function did not correlate with THALDO or THDOC excretion. In patients with CKD, 24-h USodium (r =0.614, P <0.001) and 24-h UPotassium (r =0.538, P <0.001) were positively correlated with THALDO excretion. On multivariate linear regression analysis, 24-h USod was the strongest independent predictor (P =0.004) of THALDO and THDOC excretion in CKD. In patients with EH, no relationship was seen between mineralocorticoid excretion and 24-h urinary sodium excretion.ConclusionsIn patients with CKD, 24-h urinary sodium excretion is the strongest positive predictor of urinary mineralocorticoid excretion. The nature of this relationship is unexpected, novel, not seen in patients with EH and may explain the association seen between high urinary sodium excretion, mineralocorticoids and poor outcomes in patients with CKD.
    Original languageEnglish
    Pages (from-to)1526-1532
    Number of pages7
    JournalNephrology Dialysis Transplantation
    Volume28
    Issue number6
    DOIs
    Publication statusPublished - Jun 2013

    Fingerprint Dive into the research topics of 'Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease'. Together they form a unique fingerprint.

  • Cite this